cough hypersensitivity syndrome: Clinical Trials

7 trials for cough hypersensitivity syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 not yet recruiting, 2 completed, 2 recruiting. 2 Not applicable, 2 Phase 2, 1 Early Phase 1, 1 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable2Not yet recruiting 2
Phase 22Completed 1, Recruiting 1
Early Phase 11Completed 1
Phase 11Recruiting 1
Phase 41Not yet recruiting 1

Follow cough hypersensitivity syndrome: new trials by email Literature Review of cough hypersensitivity syndrome trials Research Report on cough hypersensitivity syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A 2x2 Factorial, Randomized, Open-label Trial to Evaluate Neuromodulators and Cough Control Therapy in Patients With Refractory or Unexplained Chronic Cough
Morphine Sulphate, Morphine Sulphate + Cough Control Therapy, Pregabalin - Cough, Refractory Chronic Cough
Phase 4Not yet recruitingMcMaster University1242026-09-302026-10-19
Effects of Energy Versus Mechanical Surgical Devices on Postoperative Cough
Energy Device Vagus Nerve Transection, Mechanical Vagus Nerve Transection - Postoperative Cough, Cough Hypersensitivity Syndrome
Not applicableNot yet recruitingTongji Hospital2482026-09-012026-05-07
Mechanisms of Change in Behavioral Cough Suppression Therapy for Refractory Chronic Cough
BCS+inactive, BCS+active - Chronic Cough (CC), Refractory Chronic Cough
Phase 2RecruitingUniversity of Montana1352026-08-132026-08-18
Feasibility, Acceptability, and Safety Trial of Brief, Breath Control-Focused Acceptance and Commitment Therapy in Adults With Chronic Cough
Acceptance and Commitment Therapy (ACT) - Chronic Cough
Not applicableNot yet recruitingUniversity of North Carolina, Chapel Hill302026-08-012026-05-06
The Safety, Feasibility, and Repeatability of Inhaled ATP Cough Challenges
Adenosine 5'-triphosphate - Chronic Cough (CC), Asthma
Phase 1RecruitingMcMaster University332025-08-052025-08-29
Influence on Cough and Airway Symptoms by Oral Capsaicin
Capsicum Oleoresin, Placebos - Cough
Phase 2CompletedVastra Gotaland Region552019-06-012026-09-01
Cough Desensitization Therapy for Cough Hypersensitivity Syndrome
Supra-threshold and progressive doses of diluted capsaicin via a Koko Digidoser nebulizer, Sub-threshold doses of diluted capsiacin via a KoKo Digidoser nebulizer - Cough
Early Phase 1CompletedUniversity of Montana192019-05-012024-03-04

Narrower conditions

Chronic Cough (6)  ·  Cough (4)  ·  Asthma (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (7)  ·  Respiration Disorders (7)  ·  Respiratory Tract Diseases (7)  ·  Signs and Symptoms (7)  ·  Signs and Symptoms, Respiratory (7)  ·  Cough (3)  ·  Bronchial Diseases (1)  ·  Hypersensitivity (1)  ·  Hypersensitivity, Immediate (1)  ·  Immune System Diseases (1)  ·  Lung Diseases (1)  ·  Lung Diseases, Obstructive (1)  ·  Respiratory Hypersensitivity (1)

Interventions

Acceptance and Commitment Therapy (1)  ·  Adenosine Triphosphate (1)  ·  Capsaicin (1)  ·  Morphine (1)  ·  Pregabalin (1)  ·  oleoresins (1)

Sponsors

McMaster University (2)  ·  University of Montana (2)  ·  Tongji Hospital (1)  ·  University of North Carolina, Chapel Hill (1)  ·  Vastra Gotaland Region (1)

Countries

United States (3)  ·  Canada (2)  ·  China (1)  ·  Sweden (1)

Top investigators

Laurie J Slovarp, PhD (2)  ·  Amanda Gillespie, PhD (1)  ·  Carolyn Novaleski, Ph.D., CCC-SLP (1)  ·  Eva Millqvist, MD, PhD (1)  ·  Imran Satia, MD PhD (1)  ·  Peng Shu (1)

Results publications

PMID 35091204, PMID 42548348

NIH funding

2016 (1), K23HL169934 (1)